Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 (Q44400612)
Jump to navigation
Jump to search
scientific article published on January 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 |
scientific article published on January 1, 2003 |
Statements
1 reference
Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 (English)
1 reference
1 reference
Clara D Bloomfield
1 reference
Richard A Larson
1 reference
Wendy Stock
1 reference
Richard T. Silver
Bercedis L. Peterson
Ted P. Szatrowski
Bayard L. Powell
Andrew J. Carroll
Charles A. Schiffer
1 January 2003
1 reference
1 reference
44
1 reference
1
1 reference
39-48
1 reference
Identifiers
1 reference